Fig. 3
From: Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report
Changes in coagulation function during hospitalization. During cefminox sodium treatment, the patient’s coagulation function deteriorated, which was characterized by prolonged PT and APTT, decreased PTA and increased INR. TT didn’t change significantly. After stopping cefminox sodium treatment, all above parameters quickly returned to the basic levels. PT prothrombin time, APTT activated partial thromboplastin time, PTA prothrombin activity, INR international normalized ratio, TT bleeding time